<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosntds</journal-id><journal-title-group><journal-title>PLoS Neglected Tropical Diseases</journal-title></journal-title-group><issn pub-type="ppub">1935-2727</issn><issn pub-type="epub">1935-2735</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5287455</article-id><article-id pub-id-type="pmid">28107342</article-id><article-id pub-id-type="doi">10.1371/journal.pntd.0005319</article-id><article-id pub-id-type="publisher-id">PNTD-D-16-01680</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Tropical Diseases</subject><subj-group><subject>Neglected Tropical Diseases</subject><subj-group><subject>Chikungunya Infection</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Viral Diseases</subject><subj-group><subject>Chikungunya Infection</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Togaviruses</subject><subj-group><subject>Alphaviruses</subject><subj-group><subject>Chikungunya Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Togaviruses</subject><subj-group><subject>Alphaviruses</subject><subj-group><subject>Chikungunya Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Togaviruses</subject><subj-group><subject>Alphaviruses</subject><subj-group><subject>Chikungunya Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Togaviruses</subject><subj-group><subject>Alphaviruses</subject><subj-group><subject>Chikungunya Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Fevers</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Fevers</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pain Management</subject><subj-group><subject>Arthralgia</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>South America</subject><subj-group><subject>Brazil</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune Physiology</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune Physiology</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System Proteins</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System Proteins</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Immune System Proteins</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Serology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>North America</subject><subj-group><subject>Caribbean</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Seroprevalence of Chikungunya Virus in a Rural Community in Brazil</article-title><alt-title alt-title-type="running-head">Seroprevalence of CHIKV in Brazil</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cunha</surname><given-names>Rivaldo V.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Trinta</surname><given-names>Karen S.</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Montalbano</surname><given-names>Camila A.</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sucupira</surname><given-names>Michel V. F.</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>de Lima</surname><given-names>Maricelia M.</given-names></name><xref ref-type="aff" rid="aff005"><sup>5</sup></xref><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Marques</surname><given-names>Erenilde</given-names></name><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Romanholi</surname><given-names>Izilyanne H.</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6665-6825</contrib-id><name><surname>Croda</surname><given-names>Julio</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff007"><sup>7</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Faculty of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Oswaldo Cruz Foundation, Campo Grande, Mato Grosso do Sul, Brazil</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Bio-Manguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Faculty of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Municipal Health Department of Feira de Santana, Feira de Santana, Bahia, Brazil</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>State University of Feira de Santana, Feira de Santana, Bahia, Brazil</addr-line></aff><aff id="aff007"><label>7</label>
<addr-line>Falcuty of Health Sciences, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Barrera</surname><given-names>Roberto</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Centers for Disease Control and Prevention, Puerto Rico, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p><list list-type="simple"><list-item><p><bold>Conceptualization:</bold> RVC KST JC.</p></list-item><list-item><p><bold>Data curation:</bold> CAM MVFS MMdL EM IHR.</p></list-item><list-item><p><bold>Formal analysis:</bold> KST JC.</p></list-item><list-item><p><bold>Funding acquisition:</bold> RVC KST.</p></list-item><list-item><p><bold>Investigation:</bold> RVC KST CAM MVF MMdL EM IHR JC.</p></list-item><list-item><p><bold>Methodology:</bold> RVC JC.</p></list-item><list-item><p><bold>Project administration:</bold> RVC.</p></list-item><list-item><p><bold>Resources:</bold> RVC KST.</p></list-item><list-item><p><bold>Software:</bold> JC.</p></list-item><list-item><p><bold>Supervision:</bold> RVC JC.</p></list-item><list-item><p><bold>Validation:</bold> RVC JC.</p></list-item><list-item><p><bold>Visualization:</bold> RVC KST JC.</p></list-item><list-item><p><bold>Writing &#x02013; original draft:</bold> RVC KST JC.</p></list-item><list-item><p><bold>Writing &#x02013; review &#x00026; editing:</bold> RVC KST JC.</p></list-item></list>
</p></fn><corresp id="cor001">* E-mail: <email>julio.croda@fiocruz.br</email>, <email>juliocroda@ufgd.edu.br</email></corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>1</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2017</year></pub-date><volume>11</volume><issue>1</issue><elocation-id>e0005319</elocation-id><history><date date-type="received"><day>13</day><month>9</month><year>2016</year></date><date date-type="accepted"><day>10</day><month>1</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2017 Cunha et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Cunha et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pntd.0005319.pdf"/><abstract><sec id="sec001"><title>Background</title><p>The emergence of the Chikungunya virus (CHIKV) is currently expanding. In 2015, 38,332 cases of Chikungunya were reported to the Brazilian epidemiological surveillance system. Eighteen months after notification of the first case in the city of Feira de Santana, we conducted the first serosurvey to define the magnitude of transmission in a rural community in Brazil.</p></sec><sec id="sec002"><title>Methodology/Main findings</title><p>The serosurvey was conducted in a random sample of 450 residences in the Chapada district, located 100 kilometers from Feira de Santana. We administered questionnaires and tested 120 sera from Chapada district residents for CHIKV IgM- and IgG-specific antibodies. An individual with CHIKV infection was defined as any person with CHIKV IgM or IgG antibodies detected in the serum. One Hundred cases of Chikungunya were reported after prolonged rainfall, which reinforced the relationship between the rainfall index and CHIKV transmission. Eighteen months after the start of the outbreak, we identified a seroprevalence of 20% (95% CI, 15.4&#x02013;35%). CHIKV IgG- and IgM-specific antibodies were detected in 22/120 (18.3%) and 6/120 (5.0%) individuals, respectively. Among seropositive patients, 13/24 (54.2%) reported fever and joint pain over the previous two years (p&#x0003c;0.01). The rate of symptomatic CHIKV infection was 40.7%.</p></sec><sec id="sec003"><title>Conclusions/Significance</title><p>We identified a moderate seroprevalence of Chikungunya in the Chapada district, and in half of the confirmed CHIKV infections, patients reported arthralgia and fever over the previous two years.</p></sec></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>The Chikungunya virus (CHIKV) epidemic is currently expanding. In 2015, 38,332 cases of Chikungunya were reported to the Brazilian epidemiological surveillance system. To date, no serosurvey has described the impact of the disease on rural communities in Brazil. We conducted a survey in which households in the Chapada district, located in Riach&#x000e3;o do Jacu&#x000ed;pe in Bahia, were randomly selected for serum collection to perform a CHIKV antibody test. More than 100 cases of Chikungunya were reported in the Chapada district following a three-month period of rain. Eighteen months after the start of the outbreak, we identified that 20% of the population had acquired CHIKV, and 13/24 (54.2%) reported fever and joint pain over the previous two years. The rate of symptomatic CHIKV infection was 40.7%. We identified a moderate seroprevalence of Chikungunya in the Chapada district, and half of the patients reported arthralgia and fever over the previous two years.</p></abstract><funding-group><funding-statement>The authors are grateful to Funda&#x000e7;&#x000e3;o Oswaldo Cruz, Bio-Manguinhos and Instituto de Biologia Molecular do Paran&#x000e1; for their full support during the study period. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="2"/><table-count count="3"/><page-count count="11"/></counts><custom-meta-group><custom-meta><meta-name>PLOS Publication Stage</meta-name><meta-value>vor-update-to-uncorrected-proof</meta-value></custom-meta><custom-meta><meta-name>Publication Update</meta-name><meta-value>2017-02-01</meta-value></custom-meta><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec004"><title>Introduction</title><p>The Chikungunya virus (CHIKV) belongs to the genus <italic>Alphavirus</italic> of the family <italic>Togaviridae</italic> and has a single-stranded RNA genome and positive polarity [<xref rid="pntd.0005319.ref001" ref-type="bibr">1</xref>]. The virus was first isolated in blood samples obtained during an epidemic of a "dengue-like" disease that occurred between 1952&#x02013;1953 in Tanzania [<xref rid="pntd.0005319.ref002" ref-type="bibr">2</xref>, <xref rid="pntd.0005319.ref003" ref-type="bibr">3</xref>]. To date, four CHIKV genotypes have been identified, two of which were initially isolated in Africa: the East-Central-South-African genotype (ECSA), the West African genotype, the Asian genotype and the more recently identified Indian Ocean Lineage [<xref rid="pntd.0005319.ref004" ref-type="bibr">4</xref>, <xref rid="pntd.0005319.ref005" ref-type="bibr">5</xref>].</p><p>Clinical disease manifestations emerge after an incubation period that lasts an average of 2 to 4 days. The first symptom is usually a high fever, followed hours later by myalgia and generalized arthralgia and arthritis, which are often incapacitating and accompanied by headache and back pain. Polyarthralgia/polyarthritis is usually bilateral and symmetrical and occurs more often in the hands, wrists, interphalangeal joints, feet and ankles but may also affect large joints, such as the shoulders and knees. Periarticular swelling is frequently observed [<xref rid="pntd.0005319.ref006" ref-type="bibr">6</xref>, <xref rid="pntd.0005319.ref007" ref-type="bibr">7</xref>]. A maculopapular rash and facial swelling are present in approximately 40 to 50% of patients [<xref rid="pntd.0005319.ref008" ref-type="bibr">8</xref>]. In children, vesicobullous eruptions with intense subsequent flaking may occur, along with petechiae and gingivorrhagia. Ocular manifestations can also occur and generally achieve satisfactory resolution in six to eight weeks [<xref rid="pntd.0005319.ref006" ref-type="bibr">6</xref>, <xref rid="pntd.0005319.ref009" ref-type="bibr">9</xref>]. Chikungunya is usually self-limiting, with clinical manifestations regressing within a few weeks. However, in a percentage of those infected, which can vary from 30 to 40%, polyarthralgias may persist for months or even years [<xref rid="pntd.0005319.ref007" ref-type="bibr">7</xref>].</p><p>Although Chikungunya is usually benign, there have been increasingly frequent reports associating Chikungunya with the decompensation of pre-existing diseases, especially heart, kidney and liver diseases, diabetes, hypertension and systemic lupus erythematosus, among others [<xref rid="pntd.0005319.ref010" ref-type="bibr">10</xref>]. During the epidemics in the Caribbean and Americas between 2013 and 2014, 65 patients were admitted to intensive care units (ICUs) with Chikungunya, of whom 54 had pre-existing illnesses, and 27 were admitted due to the exacerbation of comorbidities [<xref rid="pntd.0005319.ref011" ref-type="bibr">11</xref>].</p><p>In October 2013, autochthonous CHIKV circulation was found on the island of Saint Martin and spread to different countries and territories of the Caribbean and the Americas [<xref rid="pntd.0005319.ref012" ref-type="bibr">12</xref>]. In Brazil, the first autochthonous cases of CHIKV were identified in the cities of Oiapoque, Amap&#x000e1; State and Feira de Santana, Bahia State, in September 2014 [<xref rid="pntd.0005319.ref004" ref-type="bibr">4</xref>]. The Asian genotype, which had already been isolated in Caribbean and Central American countries and territories, was identified in the first location. In the city of Feira de Santana, the detected genotype was ECSA [<xref rid="pntd.0005319.ref004" ref-type="bibr">4</xref>, <xref rid="pntd.0005319.ref013" ref-type="bibr">13</xref>]. Between late 2013 and July 2016, approximately two million cases were reported in more than forty countries and territories in the Americas and the Caribbean, with Brazil also having registered tens of thousands of cases [<xref rid="pntd.0005319.ref014" ref-type="bibr">14</xref>].</p><p>A Chikungunya epidemic began in Riach&#x000e3;o do Jacu&#x000ed;pe, Bahia in the second half of 2014 [<xref rid="pntd.0005319.ref015" ref-type="bibr">15</xref>]. Chapada is a district in Riach&#x000e3;o do Jacu&#x000ed;pe that reported a high number of cases in 2014 and 2015. The Chapada district is a small, restricted geographic region with 100% basic health care coverage, which would facilitate the performance of a seroepidemiological survey. Therefore, to determine the prevalence of anti-CHIKV antibodies after the first wave of the epidemic, a serosurvey was conducted in the District of Chapada, a rural community of Riach&#x000e3;o do Jacu&#x000ed;pe.</p></sec><sec sec-type="materials|methods" id="sec005"><title>Methods</title><sec id="sec006"><title>Study location</title><p>Riach&#x000e3;o do Jacu&#x000ed;pe has an area of 1,190.215 km<sup>2</sup> and is located 100 km from the city of Feira de Santana, where the first case was identified in Northeastern Brazil. It has an estimated population of 33,000 inhabitants and a Human Development Index (HDI) of 0.628. The Chapada district is 17 km from the administrative headquarters of Riach&#x000e3;o Jacu&#x000ed;pe and has a population of 2,303 inhabitants [<xref rid="pntd.0005319.ref016" ref-type="bibr">16</xref>]. The population is mainly rural, and farm work is the main economic activity of its inhabitants.</p></sec><sec id="sec007"><title>Study design and sample selection</title><p>This serosurvey was conducted in April 2016. The Chapada district has a total of 505 households, with 2,303 individuals. Cluster sampling was performed, using the household as a sample unit. To calculate the sample size, we estimated a prevalence of 20% with a variation of &#x000b1; 10, 80% power, type I error of 5%, and a correction for survey design by an aggregate of 2. Therefore, it was necessary to select 120 individuals, increasing this number by 20% for losses. We conducted a random selection of 45 households and selected 160 individuals to compose the sample.</p></sec><sec id="sec008"><title>Laboratory diagnosis and definition of CHIKV infection</title><p>Blood samples were collected by venipuncture, and serum was separated by centrifugation (3.000 rpm/5 minutes). The serum was stored at&#x02014;20&#x000b0;C until use. The search for anti-CHIKV IgM- and IgG-specific antibodies was performed using a commercial ELISA (enzyme-linked immunosorbent assay) according to the manufacturer's instructions (Euroimmun, L&#x000fc;beck, Schleswig-Holstein, Germany). An individual with CHIKV infection was defined as any person with IgM or IgG CHIKV antibodies detected in the serum.</p></sec><sec id="sec009"><title>Definition of symptomatic individuals and rate of symptomatic CHIKV infection</title><p>An individual was considered to have had symptomatic infection if he/she had experienced fever and arthralgia in the previous two years and if a test for IgM and/or IgG detection had yielded positive results. To calculate the symptomatic rate of Chikungunya, we subtracted the rate of individuals who had fever, arthralgia and negative CHIKV serology from the rate of individuals who had fever, arthralgia and positive CHIKV serology.</p></sec><sec id="sec010"><title>Secondary sources of data</title><p>Chikungunya is a mandatory reportable disease, and the reporting system relies on the notification of all suspected cases at public and private health facilities based on the attending clinician&#x02019;s initial clinical diagnosis (not laboratory confirmed). A suspected case is defined as illness in a person from an area of Chikungunya transmission or Aedes aegypti mosquito infestation who has symptoms of Chikungunya (sudden onset fever greater than 38.5&#x000b0;C and arthralgia or acute arthritis, unexplained by other conditions). The Sistema Nacional de Informa&#x000e7;&#x000e3;o do Minist&#x000e9;rio da Sa&#x000fa;de (SINAN) is the Brazilian Ministry of Health's National Information System for entering and processing the data for reported Chikungunya cases throughout Brazil, and the notification rate is calculated by dividing the number of Chikungunya cases reported to SINAN by the total population.</p></sec><sec id="sec011"><title>Data analysis and ethical considerations</title><p>The interviews were conducted with the aid of a notebook. Data were entered directly into Research Electronic Data Capture (REDCap), hosted at the Federal University of Grande Dourados [<xref rid="pntd.0005319.ref017" ref-type="bibr">17</xref>], and were analyzed using the statistical program SAS 9.2 (SAS Institute, Cary, NC, USA). The incidence and prevalence of Chikungunya are expressed as percentages with 95% confidence intervals. Dichotomized and categorical data were analyzed with the chi-squared test. The following data were collected on the questionnaire: age, sex, educational attainment, previous fever or joint pain in the last two years and medical history of dengue, Chikungunya and Zika. The participant&#x02019;s race/ethnicity (i.e., white, black, indigenous, Asian or mixed) was self-reported. All eligible participants provided written informed consent prior to study participation. The study was approved by the Research Ethics Committee at the State University of Feira de Santana (CAAE study number: 49946515.6.0000.0053. Institutional review board approval number: 1.450.762).</p></sec></sec><sec sec-type="results" id="sec012"><title>Results</title><p>The first suspected case of Chikungunya in the Chapada district was reported in October 2014. By October 2015, over 100 cases had been reported, with 35% serologically confirmed and 30 anti-CHIKV IgM-positive cases and 5 anti-CHIKV IgG-positive cases (<xref ref-type="fig" rid="pntd.0005319.g001">Fig 1</xref>). The notification rate over the one-year period was 4.3% (95% CI, 3.5%-5.3%), and all of the reported cases involved joint pain and fever. The notification rate in in the Chapada district was similar from the notification rate over the same period in Riach&#x000e3;o do Jacu&#x000ed;pe (6.7%; 95% CI, 6.4%-7.0%).</p><fig id="pntd.0005319.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005319.g001</object-id><label>Fig 1</label><caption><title>Numbers of CHIKV cases, anti-CHIKV IgM status and monthly precipitation in the Chapada district between October 2014 and November 2015.</title></caption><graphic xlink:href="pntd.0005319.g001"/></fig><p>In the serosurvey, of the 160 individuals selected, 120 were present in their homes and agreed to participate in the study (<xref ref-type="fig" rid="pntd.0005319.g002">Fig 2</xref>). Randomly recruited individuals did not significantly differ from the general population of the Chapada district with respect to age and gender (<xref ref-type="supplementary-material" rid="pntd.0005319.s001">S1 Table</xref>).</p><fig id="pntd.0005319.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005319.g002</object-id><label>Fig 2</label><caption><title>Flow chart of the study enrollment and CHIKV IgM and IgG antibody positivity rates.</title></caption><graphic xlink:href="pntd.0005319.g002"/></fig><p>Differences in the age and sex of the individuals who agreed and declined to participate in the study were not observed. Most individuals were female, 62/120 (51.7%), and young, with a mean age of 36.6&#x000b1;20.9, were black, 45/117 (38.5%), or of mixed race, 69/117 (59.0%), and were not working, 30/120 (25%), at the time of the survey. Of the individuals evaluated, 15/120 (12.5%) reported a previous clinical diagnosis of Chikungunya, and 44/120 (36.7%) and 30/120 (25.0%) reported at least one episode of fever or joint pain, respectively, in the previous 2 years (<xref rid="pntd.0005319.t001" ref-type="table">Table 1</xref>).</p><table-wrap id="pntd.0005319.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005319.t001</object-id><label>Table 1</label><caption><title>Description of 120 individuals enrolled in the serosurvey in the Chapada district.</title></caption><alternatives><graphic id="pntd.0005319.t001g" xlink:href="pntd.0005319.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="left" rowspan="1" colspan="1">N (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Sociodemographics</bold></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Sex, Female</bold></td><td align="left" rowspan="1" colspan="1">62 (51.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Age groups (years)</bold><xref ref-type="table-fn" rid="t001fn001"><sup>1</sup></xref></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;0&#x02013;14</td><td align="left" rowspan="1" colspan="1">22 (18.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;15&#x02013;29</td><td align="left" rowspan="1" colspan="1">30 (25.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;30&#x02013;44</td><td align="left" rowspan="1" colspan="1">28 (23.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;45&#x02013;59</td><td align="left" rowspan="1" colspan="1">20 (16.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02265;60</td><td align="left" rowspan="1" colspan="1">19 (16.0%)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Race</bold><xref ref-type="table-fn" rid="t001fn002"><sup>2</sup></xref></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;White</td><td align="left" rowspan="1" colspan="1">3 (2.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Mixed</td><td align="left" rowspan="1" colspan="1">69 (59.0%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Black</td><td align="left" rowspan="1" colspan="1">45 (38.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Less than 4 years of schooling</bold></td><td align="left" rowspan="1" colspan="1">53 (44.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Occupation</bold></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Unemployed</td><td align="left" rowspan="1" colspan="1">30 (25.0%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Student</td><td align="left" rowspan="1" colspan="1">30 (25.0%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Retired</td><td align="left" rowspan="1" colspan="1">14 (11.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Rural work</td><td align="left" rowspan="1" colspan="1">16 (13.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Others</td><td align="left" rowspan="1" colspan="1">30 (25.0%)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Clinical symptoms</bold></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Fever in the last 2 years</bold></td><td align="left" rowspan="1" colspan="1">44 (36.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Joint pain in the last 2 years</bold></td><td align="left" rowspan="1" colspan="1">30 (25.0%)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Prior clinical diagnosis in the last 2 years</bold></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Dengue</td><td align="left" rowspan="1" colspan="1">7 (5.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Zika</td><td align="left" rowspan="1" colspan="1">6 (5.0%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Chikungunya</td><td align="left" rowspan="1" colspan="1">15 (12.5%)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p><sup>1</sup> Information available for 119 individuals</p></fn><fn id="t001fn002"><p><sup>2</sup> Information available for 117 individuals</p></fn></table-wrap-foot></table-wrap><p>Among the 120 individuals evaluated, 22/120 (18.3%) were anti-CHIKV IgG-positive, and 06/120 (5.0%) were anti-CHIKV IgM-positive. Three samples were borderline on the test used. Among the six patients who had CHIKV-specific IgM, four (66.7%) also showed CHIKV specific-IgG antibodies, for an overall prevalence of 20% (95% CI, 15.4&#x02013;35.7%) (<xref rid="pntd.0005319.t002" ref-type="table">Table 2</xref>).</p><table-wrap id="pntd.0005319.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005319.t002</object-id><label>Table 2</label><caption><title>Seroprevalence of IgM and IgG antibodies against CHIKV in Chapada, April 2016 (N = 120).</title></caption><alternatives><graphic id="pntd.0005319.t002g" xlink:href="pntd.0005319.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">IgG</th><th align="left" rowspan="1" colspan="1">IgM</th><th align="left" rowspan="1" colspan="1">IgG and/or IgM</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Positive</bold></td><td align="left" rowspan="1" colspan="1">22 (18.3%)</td><td align="left" rowspan="1" colspan="1">6 (5.0%)</td><td align="left" rowspan="1" colspan="1">24 (20.0%)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Negative</bold></td><td align="left" rowspan="1" colspan="1">98 (81.7%)</td><td align="left" rowspan="1" colspan="1">111 (92.5%)</td><td align="left" rowspan="1" colspan="1">94 (78.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Borderline</bold></td><td align="left" rowspan="1" colspan="1">0 (0%)</td><td align="left" rowspan="1" colspan="1">03 (2.5%)</td><td align="left" rowspan="1" colspan="1">02 (1.7%)</td></tr></tbody></table></alternatives></table-wrap><p>Among the patients with positive serology, 16/24 (66.7%) suffered fever episodes, and 13/24 (54.2%) reported joint pain and fever over the previous two years (p&#x0003c;0.01). Among 96 patients with negative serology, 13 (13.5%) had fever and joint pain. According to the criteria defined for this study, the rate of symptomatic CHIKV infection was 40.7%. Furthermore, 54.2% reported having had a clinical diagnosis of Chikungunya (p&#x0003c;0.01) (<xref rid="pntd.0005319.t003" ref-type="table">Table 3</xref>).</p><table-wrap id="pntd.0005319.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005319.t003</object-id><label>Table 3</label><caption><title>Comparison of individuals with CHIKV IgG- and/or IgM-positive and negative antibodies in the Chapada district (N = 120).</title></caption><alternatives><graphic id="pntd.0005319.t003g" xlink:href="pntd.0005319.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Positive (N = 24)</th><th align="left" rowspan="1" colspan="1">Negative (N = 96)</th><th align="left" rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Sex, Female</bold></td><td align="left" rowspan="1" colspan="1">10 (41.7%)</td><td align="left" rowspan="1" colspan="1">52 (54.2%)</td><td align="char" char="." rowspan="1" colspan="1">0.27</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Age groups (years)</bold><xref ref-type="table-fn" rid="t003fn001"><sup>1</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.94</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;0&#x02013;15</td><td align="left" rowspan="1" colspan="1">3 (13.0%)</td><td align="left" rowspan="1" colspan="1">19 (19.8%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x0003e;15&#x02013;30</td><td align="left" rowspan="1" colspan="1">7 (30.4%)</td><td align="left" rowspan="1" colspan="1">23 (24.0%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x0003e;30&#x02013;45</td><td align="left" rowspan="1" colspan="1">6 (26.1%)</td><td align="left" rowspan="1" colspan="1">22 (22.9%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x0003e;45&#x02013;60</td><td align="left" rowspan="1" colspan="1">4 (17.4%)</td><td align="left" rowspan="1" colspan="1">16 (16.7%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x0003e;60</td><td align="left" rowspan="1" colspan="1">3 (13.0%)</td><td align="left" rowspan="1" colspan="1">16 (16.7%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Race</bold><xref ref-type="table-fn" rid="t003fn001"><sup>1</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.74</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;White</td><td align="left" rowspan="1" colspan="1">0 (0.0%)</td><td align="left" rowspan="1" colspan="1">3 (3.1%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Mixed</td><td align="left" rowspan="1" colspan="1">15 (65.2%)</td><td align="left" rowspan="1" colspan="1">54 (56.3%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Black</td><td align="left" rowspan="1" colspan="1">8 (34.8%)</td><td align="left" rowspan="1" colspan="1">37 (38.5%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Less than 4 years of schooling</bold></td><td align="left" rowspan="1" colspan="1">8 (33.3%)</td><td align="left" rowspan="1" colspan="1">45 (46.9%)</td><td align="char" char="." rowspan="1" colspan="1">0.23</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Fever in the last 2 years</bold></td><td align="left" rowspan="1" colspan="1">16 (66.7%)</td><td align="left" rowspan="1" colspan="1">28 (29.2%)</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Joint pain in the last 2 years</bold></td><td align="left" rowspan="1" colspan="1">13 (54.2%)</td><td align="left" rowspan="1" colspan="1">17 (17.7%)</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Fever and joint pain in the last 2 years</bold></td><td align="left" rowspan="1" colspan="1">13 (54.2%)</td><td align="left" rowspan="1" colspan="1">13 (13.5%)</td><td align="char" char="." rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Prior clinical diagnosis in the last 2 years</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Dengue</td><td align="left" rowspan="1" colspan="1">0 (0%)</td><td align="left" rowspan="1" colspan="1">7 (7.3%)</td><td align="char" char="." rowspan="1" colspan="1">0.40*</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Zika</td><td align="left" rowspan="1" colspan="1">2 (8.3%)</td><td align="left" rowspan="1" colspan="1">4 (4.2%)</td><td align="char" char="." rowspan="1" colspan="1">0.69*</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Chikungunya</td><td align="left" rowspan="1" colspan="1">13 (54.2%)</td><td align="left" rowspan="1" colspan="1">2 (2.1%)</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.01*</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p><sup>1</sup>Information available for 23 individuals</p></fn><fn id="t003fn002"><p><sup>2</sup>Fisher's exact test</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="conclusions" id="sec013"><title>Discussion</title><p>This report describes the first serosurvey in a rural community in Northeastern Brazil. The seroprevalence found in the Chapada district was 20%, in other serosurveys, the prevalence of anti-CHIKV antibodies has ranged between 10.2% and 75% [<xref rid="pntd.0005319.ref018" ref-type="bibr">18</xref>, <xref rid="pntd.0005319.ref019" ref-type="bibr">19</xref>]. The difference between the prevalence found in this study and those reported by other serosurveys may be associated with local environmental conditions and/or vector competence in transmitting the ECSA strain of CHIKV, which was introduced in Brazil in 2013 [<xref rid="pntd.0005319.ref013" ref-type="bibr">13</xref>]. In addition, the interval between the time the serosurvey was conducted and the peak of outbreak could have affected the prevalence rates reported in different cross-sectional studies [<xref rid="pntd.0005319.ref018" ref-type="bibr">18</xref>, <xref rid="pntd.0005319.ref020" ref-type="bibr">20</xref>, <xref rid="pntd.0005319.ref021" ref-type="bibr">21</xref>].</p><p>The Chapada district has a population of 2,303, and during the year in which the outbreak occurred, 100 Chikungunya cases were reported. The attack rate found in the Chapada district may eventually be applied to Riach&#x000e3;o do Jacu&#x000ed;pe and other cities that present climatic conditions and a similar Aedes infestation index in Brazil. Based on the number of notifications and serosurvey results, we can estimate that for every reported case, 1.9 cases of symptomatic CHIKV infection were not reported during the outbreak, demonstrating the difficulty that the surveillance system faces in identifying suspected Chikungunya cases. Nevertheless, the underreporting rate is still much lower than that recorded for dengue, wherein for each case reported, 12 are not reported in the Brazilian Ministry of Health's National Information System [<xref rid="pntd.0005319.ref022" ref-type="bibr">22</xref>].</p><p>The Chapada district is located in a semi-arid region of Bahia, 100 km from Feira de Santana, where the first case of Chikungunya was identified in Brazil [<xref rid="pntd.0005319.ref004" ref-type="bibr">4</xref>]. Interestingly, the peak in Chikungunya outbreak notifications occurred in September 2015 and was preceded by a very rainy period between April and June 2015. This condition may have been crucial to the reproduction and multiplication of the <italic>Aedes</italic> vector and may consequently have affected the occurrence of the outbreak in 2015. It must be taken in account that environmental factors are important in the occurrence of Chikungunya outbreaks. Studies conducted on the island of Saint Martin [<xref rid="pntd.0005319.ref018" ref-type="bibr">18</xref>] and in Feira de Santana [<xref rid="pntd.0005319.ref023" ref-type="bibr">23</xref>] and mathematical modeling studies conducted in American and Asian countries clearly demonstrate the relationship between temperature, rainfall and the increase in the number of Chikungunya notifications [<xref rid="pntd.0005319.ref024" ref-type="bibr">24</xref>].</p><p>The majority of randomly selected individuals were unemployed, children and retirees (61.7%), and half of the population had less than four years of schooling 44.2% (53/120). Of the 24 positive cases, 54.2% (13/24) reported significant arthralgia in the previous two years, and the rate of symptomatic Chikungunya infection was 40.7%. Chikungunya epidemics have become a serious public health problem, especially in the poorest communities, where health care systems are more precarious. The broad spectrum of post-Chikungunya musculoskeletal and rheumatic disorders, which can evolve chronically and are often disabling, [<xref rid="pntd.0005319.ref025" ref-type="bibr">25</xref>] compromise the local work force and affect the family incomes of these most vulnerable populations.</p><p>Arthralgia is one of the Brazilian Ministry of Health&#x02019;s clinical criteria for case definition. Despite the fact that all 100 reported patients during the outbreak experienced this symptom, only 54.2% of patients with CHIKV-specific antibodies in the serosurvey reported the presence of this symptom in the previous 2 years, and 54.2% reported having had a clinical diagnosis of Chikungunya. Similar frequencies of patients without arthralgia have also been described in the ECSA lineage outbreaks that occurred in Thailand, Kenya and Saint Martin [<xref rid="pntd.0005319.ref018" ref-type="bibr">18</xref>, <xref rid="pntd.0005319.ref021" ref-type="bibr">21</xref>, <xref rid="pntd.0005319.ref026" ref-type="bibr">26</xref>]. Asymptomatic and oligosymptomatic patients are fundamental to the maintenance of a local epidemic. There is always the possibility of recall bias in serosurveys. However, Chikungunya-induced arthralgia is usually marked; thus, we believe that information obtained retrospectively would not have suffered from any study design effect.</p><p>This study has important limitations inherent to its design. A major example of these limitations is that 40 individuals (25%) were not at home, which can lead to selection bias, as demonstrated by the higher proportions of women, children and elderly. Nonetheless, we observed no differences in relation to age and sex between the individuals who agreed and declined to participate in the study and compared to the general population.</p><p>In summary, the incidence of CHIKV infection during an outbreak in the Chapada district was 20% (95% CI 15.4&#x02013;35.7%). The outbreak was preceded by a 3-month rainy period, which is unusual for this district and which may have affected the reproduction and multiplication of the <italic>Aedes</italic> vector. In addition to the substantial suffering associated with persistent arthralgia, the outbreak in this community of rural workers likely had a significant economic impact on the region.</p></sec><sec sec-type="supplementary-material" id="sec014"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pntd.0005319.s001"><label>S1 Table</label><caption><title>Comparison among the individuals enrolled in the serosurvey and the general population in the Chapada district.</title><p>(DOCX)</p></caption><media xlink:href="pntd.0005319.s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0005319.s002"><label>S1 Dataset</label><caption><title>CHIKVchapada.</title><p>(CSV)</p></caption><media xlink:href="pntd.0005319.s002.csv"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0005319.s003"><label>S1 Checklist</label><caption><p>(DOC)</p></caption><media xlink:href="pntd.0005319.s003.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank the participants, without whom this study could not have been performed. Our appreciation also extends to Melissa Falc&#x000e3;o, Laysa Bezerra, Djalma de Oliveira and the staff of Secretaria Municipal de Sa&#x000fa;de de Feira de Santana and Riach&#x000e3;o do Jacu&#x000ed;pe and the health center of the Chapada district.</p></ack><ref-list><title>References</title><ref id="pntd.0005319.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Strauss</surname><given-names>JH</given-names></name>, <name><surname>Strauss</surname><given-names>EG</given-names></name>. <article-title>The alphaviruses: gene expression, replication, and evolution</article-title>. <source>Microbiol Rev</source>. <year>1994</year>;<volume>58</volume>(<issue>3</issue>):<fpage>491</fpage>&#x02013;<lpage>562</lpage>. <?supplied-pmid 7968923?><pub-id pub-id-type="pmid">7968923</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Lumsden</surname><given-names>WH</given-names></name>. <article-title>An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952&#x02013;53. II. General description and epidemiology</article-title>. <source>Trans R Soc Trop Med Hyg</source>. <year>1955</year>;<volume>49</volume>(<issue>1</issue>):<fpage>33</fpage>&#x02013;<lpage>57</lpage>. <?supplied-pmid 14373835?><pub-id pub-id-type="pmid">14373835</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Ross</surname><given-names>RW</given-names></name>. <article-title>The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic</article-title>. <source>J Hyg (Lond)</source>. <year>1956</year>;<volume>54</volume>(<issue>2</issue>):<fpage>177</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">13346078</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Nunes</surname><given-names>MR</given-names></name>, <name><surname>Faria</surname><given-names>NR</given-names></name>, <name><surname>de Vasconcelos</surname><given-names>JM</given-names></name>, <name><surname>Golding</surname><given-names>N</given-names></name>, <name><surname>Kraemer</surname><given-names>MU</given-names></name>, <name><surname>de Oliveira</surname><given-names>LF</given-names></name>, <etal>et al</etal>
<article-title>Emergence and potential for spread of Chikungunya virus in Brazil</article-title>. <source>BMC Med</source>. <year>2015</year>;<volume>13</volume>:<fpage>102</fpage>
<pub-id pub-id-type="doi">10.1186/s12916-015-0348-x</pub-id>
<?supplied-pmid 25976325?><pub-id pub-id-type="pmid">25976325</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Weaver</surname><given-names>SC</given-names></name>, <name><surname>Forrester</surname><given-names>NL</given-names></name>. <article-title>Chikungunya: Evolutionary history and recent epidemic spread</article-title>. <source>Antiviral Res</source>. <year>2015</year>;<volume>120</volume>:<fpage>32</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2015.04.016</pub-id>
<?supplied-pmid 25979669?><pub-id pub-id-type="pmid">25979669</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Pialoux</surname><given-names>G</given-names></name>, <name><surname>Gauzere</surname><given-names>BA</given-names></name>, <name><surname>Jaureguiberry</surname><given-names>S</given-names></name>, <name><surname>Strobel</surname><given-names>M</given-names></name>. <article-title>Chikungunya, an epidemic arbovirosis</article-title>. <source>Lancet Infect Dis</source>. <year>2007</year>;<volume>7</volume>(<issue>5</issue>):<fpage>319</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(07)70107-X</pub-id>
<?supplied-pmid 17448935?><pub-id pub-id-type="pmid">17448935</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Schwartz</surname><given-names>O</given-names></name>, <name><surname>Albert</surname><given-names>ML</given-names></name>. <article-title>Biology and pathogenesis of chikungunya virus</article-title>. <source>Nat Rev Microbiol</source>. <year>2010</year>;<volume>8</volume>(<issue>7</issue>):<fpage>491</fpage>&#x02013;<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2368</pub-id>
<?supplied-pmid 20551973?><pub-id pub-id-type="pmid">20551973</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Thiberville</surname><given-names>SD</given-names></name>, <name><surname>Boisson</surname><given-names>V</given-names></name>, <name><surname>Gaudart</surname><given-names>J</given-names></name>, <name><surname>Simon</surname><given-names>F</given-names></name>, <name><surname>Flahault</surname><given-names>A</given-names></name>, <name><surname>de Lamballerie</surname><given-names>X</given-names></name>. <article-title>Chikungunya fever: a clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2013</year>;<volume>7</volume>(<issue>1</issue>):<fpage>e2004</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0002004</pub-id>
<?supplied-pmid 23350006?><pub-id pub-id-type="pmid">23350006</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Horcada</surname><given-names>ML</given-names></name>, <name><surname>Diaz-Calderon</surname><given-names>C</given-names></name>, <name><surname>Garrido</surname><given-names>L</given-names></name>. <article-title>Chikungunya fever. Rheumatic manifestations of an emerging disease in Europe</article-title>. <source>Reumatol Clin</source>. <year>2015</year>;<volume>11</volume>(<issue>3</issue>):<fpage>161</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.reuma.2014.07.005</pub-id>
<?supplied-pmid 25192946?><pub-id pub-id-type="pmid">25192946</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Simon</surname><given-names>F</given-names></name>, <name><surname>Javelle</surname><given-names>E</given-names></name>, <name><surname>Cabie</surname><given-names>A</given-names></name>, <name><surname>Bouquillard</surname><given-names>E</given-names></name>, <name><surname>Troisgros</surname><given-names>O</given-names></name>, <name><surname>Gentile</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>French guidelines for the management of chikungunya (acute and persistent presentations). November 2014</article-title>. <source>Med Mal Infect</source>. <year>2015</year>;<volume>45</volume>(<issue>7</issue>):<fpage>243</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.medmal.2015.05.007</pub-id>
<?supplied-pmid 26119684?><pub-id pub-id-type="pmid">26119684</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Crosby</surname><given-names>L</given-names></name>, <name><surname>Perreau</surname><given-names>C</given-names></name>, <name><surname>Madeux</surname><given-names>B</given-names></name>, <name><surname>Cossic</surname><given-names>J</given-names></name>, <name><surname>Armand</surname><given-names>C</given-names></name>, <name><surname>Herrmann-Storke</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Severe manifestations of chikungunya virus in critically ill patients during the 2013&#x02013;2014 Caribbean outbreak</article-title>. <source>Int J Infect Dis</source>. <year>2016</year>;<volume>48</volume>:<fpage>78</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2016.05.010</pub-id>
<?supplied-pmid 27208636?><pub-id pub-id-type="pmid">27208636</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Cassadou</surname><given-names>S</given-names></name>, <name><surname>Boucau</surname><given-names>S</given-names></name>, <name><surname>Petit-Sinturel</surname><given-names>M</given-names></name>, <name><surname>Huc</surname><given-names>P</given-names></name>, <name><surname>Leparc-Goffart</surname><given-names>I</given-names></name>, <name><surname>Ledrans</surname><given-names>M</given-names></name>. <article-title>Emergence of chikungunya fever on the French side of Saint Martin island, October to December 2013</article-title>. <source>Euro Surveill</source>. <year>2014</year>;<volume>19</volume>(<issue>13</issue>).</mixed-citation></ref><ref id="pntd.0005319.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Teixeira</surname><given-names>MG</given-names></name>, <name><surname>Andrade</surname><given-names>AM</given-names></name>, <name><surname>Costa Mda</surname><given-names>C</given-names></name>, <name><surname>Castro</surname><given-names>JN</given-names></name>, <name><surname>Oliveira</surname><given-names>FL</given-names></name>, <name><surname>Goes</surname><given-names>CS</given-names></name>, <etal>et al</etal>
<article-title>East/Central/South African genotype chikungunya virus, Brazil, 2014</article-title>. <source>Emerg Infect Dis</source>. <year>2015</year>;<volume>21</volume>(<issue>5</issue>):<fpage>906</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.3201/eid2105.141727</pub-id>
<?supplied-pmid 25898939?><pub-id pub-id-type="pmid">25898939</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Fernandez-Salas</surname><given-names>I</given-names></name>, <name><surname>Diaz-Gonzalez</surname><given-names>EE</given-names></name>, <name><surname>Lopez-Gatell</surname><given-names>H</given-names></name>, <name><surname>Alpuche-Aranda</surname><given-names>C</given-names></name>. <article-title>Chikugunya and zika virus dissemination in the Americas: different arboviruses reflecting the same spreading routes and poor vector-control policies</article-title>. <source>Curr Opin Infect Dis</source>. <year>2016</year>.</mixed-citation></ref><ref id="pntd.0005319.ref015"><label>15</label><mixed-citation publication-type="other">BOLETIM EPIDEMIOLO&#x000d3;GICO DA FEBRE CHIKUNGUNYA NA BAHIA, 2014: Secretaria de Sa&#x000fa;de do Estado da Bahia; [07/30/2016]. <ext-link ext-link-type="uri" xlink:href="http://www.suvisa.ba.gov.br/sites/default/files/Boletim_Chikungunya_BA_N1_30092014.pdf">http://www.suvisa.ba.gov.br/sites/default/files/Boletim_Chikungunya_BA_N1_30092014.pdf</ext-link>.</mixed-citation></ref><ref id="pntd.0005319.ref016"><label>16</label><mixed-citation publication-type="other">Resultado da amostra do censo demogr&#x000e1;fico 2010 [Internet]. 2010 [cited 12/21/2016]. <ext-link ext-link-type="uri" xlink:href="http://www.ibge.gov.br">http://www.ibge.gov.br</ext-link></mixed-citation></ref><ref id="pntd.0005319.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Harris</surname><given-names>PA</given-names></name>, <name><surname>Taylor</surname><given-names>R</given-names></name>, <name><surname>Thielke</surname><given-names>R</given-names></name>, <name><surname>Payne</surname><given-names>J</given-names></name>, <name><surname>Gonzalez</surname><given-names>N</given-names></name>, <name><surname>Conde</surname><given-names>JG</given-names></name>. <article-title>Research electronic data capture (REDCap)&#x02014;a metadata-driven methodology and workflow process for providing translational research informatics support</article-title>. <source>J Biomed Inform</source>. <year>2009</year>;<volume>42</volume>(<issue>2</issue>):<fpage>377</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbi.2008.08.010</pub-id>
<?supplied-pmid 18929686?><pub-id pub-id-type="pmid">18929686</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Gay</surname><given-names>N</given-names></name>, <name><surname>Rousset</surname><given-names>D</given-names></name>, <name><surname>Huc</surname><given-names>P</given-names></name>, <name><surname>Matheus</surname><given-names>S</given-names></name>, <name><surname>Ledrans</surname><given-names>M</given-names></name>, <name><surname>Rosine</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Seroprevalence of Asian Lineage Chikungunya Virus Infection on Saint Martin Island, 7 Months After the 2013 Emergence</article-title>. <source>Am J Trop Med Hyg</source>. <year>2016</year>;<volume>94</volume>(<issue>2</issue>):<fpage>393</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.15-0308</pub-id>
<?supplied-pmid 26643536?><pub-id pub-id-type="pmid">26643536</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Kuan</surname><given-names>G</given-names></name>, <name><surname>Ramirez</surname><given-names>S</given-names></name>, <name><surname>Gresh</surname><given-names>L</given-names></name>, <name><surname>Ojeda</surname><given-names>S</given-names></name>, <name><surname>Melendez</surname><given-names>M</given-names></name>, <name><surname>Sanchez</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Seroprevalence of Anti-Chikungunya Virus Antibodies in Children and Adults in Managua, Nicaragua, After the First Chikungunya Epidemic, 2014&#x02013;2015</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2016</year>;<volume>10</volume>(<issue>6</issue>):<fpage>e0004773</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0004773</pub-id>
<?supplied-pmid 27322692?><pub-id pub-id-type="pmid">27322692</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Moro</surname><given-names>ML</given-names></name>, <name><surname>Gagliotti</surname><given-names>C</given-names></name>, <name><surname>Silvi</surname><given-names>G</given-names></name>, <name><surname>Angelini</surname><given-names>R</given-names></name>, <name><surname>Sambri</surname><given-names>V</given-names></name>, <name><surname>Rezza</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Chikungunya virus in North-Eastern Italy: a seroprevalence survey</article-title>. <source>Am J Trop Med Hyg</source>. <year>2010</year>;<volume>82</volume>(<issue>3</issue>):<fpage>508</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.2010.09-0322</pub-id>
<?supplied-pmid 20207883?><pub-id pub-id-type="pmid">20207883</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Sergon</surname><given-names>K</given-names></name>, <name><surname>Njuguna</surname><given-names>C</given-names></name>, <name><surname>Kalani</surname><given-names>R</given-names></name>, <name><surname>Ofula</surname><given-names>V</given-names></name>, <name><surname>Onyango</surname><given-names>C</given-names></name>, <name><surname>Konongoi</surname><given-names>LS</given-names></name>, <etal>et al</etal>
<article-title>Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004</article-title>. <source>Am J Trop Med Hyg</source>. <year>2008</year>;<volume>78</volume>(<issue>2</issue>):<fpage>333</fpage>&#x02013;<lpage>7</lpage>. <?supplied-pmid 18256441?><pub-id pub-id-type="pmid">18256441</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Silva</surname><given-names>MM</given-names></name>, <name><surname>Rodrigues</surname><given-names>MS</given-names></name>, <name><surname>Paploski</surname><given-names>IA</given-names></name>, <name><surname>Kikuti</surname><given-names>M</given-names></name>, <name><surname>Kasper</surname><given-names>AM</given-names></name>, <name><surname>Cruz</surname><given-names>JS</given-names></name>, <etal>et al</etal>
<article-title>Accuracy of Dengue Reporting by National Surveillance System, Brazil</article-title>. <source>Emerg Infect Dis</source>. <year>2016</year>;<volume>22</volume>(<issue>2</issue>):<fpage>336</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3201/eid2202.150495</pub-id>
<?supplied-pmid 26812472?><pub-id pub-id-type="pmid">26812472</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Rodrigues Faria</surname><given-names>N</given-names></name>, <name><surname>Lourenco</surname><given-names>J</given-names></name>, <name><surname>Marques de Cerqueira</surname><given-names>E</given-names></name>, <name><surname>Maia de Lima</surname><given-names>M</given-names></name>, <name><surname>Pybus</surname><given-names>O</given-names></name>, <name><surname>Carlos Alcantara</surname><given-names>L</given-names><suffix>Junior</suffix></name>. <article-title>Epidemiology of Chikungunya Virus in Bahia, Brazil, 2014&#x02013;2015</article-title>. <source>PLoS Curr</source>. <year>2016</year>;<volume>8</volume>.</mixed-citation></ref><ref id="pntd.0005319.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Perkins</surname><given-names>TA</given-names></name>, <name><surname>Metcalf</surname><given-names>CJ</given-names></name>, <name><surname>Grenfell</surname><given-names>BT</given-names></name>, <name><surname>Tatem</surname><given-names>AJ</given-names></name>. <article-title>Estimating drivers of autochthonous transmission of chikungunya virus in its invasion of the americas</article-title>. <source>PLoS Curr</source>. <year>2015</year>;<volume>7</volume>.</mixed-citation></ref><ref id="pntd.0005319.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Foissac</surname><given-names>M</given-names></name>, <name><surname>Javelle</surname><given-names>E</given-names></name>, <name><surname>Ray</surname><given-names>S</given-names></name>, <name><surname>Guerin</surname><given-names>B</given-names></name>, <name><surname>Simon</surname><given-names>F</given-names></name>. <article-title>Post-Chikungunya rheumatoid arthritis, Saint Martin</article-title>. <source>Emerg Infect Dis</source>. <year>2015</year>;<volume>21</volume>(<issue>3</issue>):<fpage>530</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.3201/eid2103.141397</pub-id>
<?supplied-pmid 25695499?><pub-id pub-id-type="pmid">25695499</pub-id></mixed-citation></ref><ref id="pntd.0005319.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Nakkhara</surname><given-names>P</given-names></name>, <name><surname>Chongsuvivatwong</surname><given-names>V</given-names></name>, <name><surname>Thammapalo</surname><given-names>S</given-names></name>. <article-title>Risk factors for symptomatic and asymptomatic chikungunya infection</article-title>. <source>Trans R Soc Trop Med Hyg</source>. <year>2013</year>;<volume>107</volume>(<issue>12</issue>):<fpage>789</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1093/trstmh/trt083</pub-id>
<?supplied-pmid 24052594?><pub-id pub-id-type="pmid">24052594</pub-id></mixed-citation></ref></ref-list></back></article>